Utama › Kanser Pundi Kencing Bukan Invasif Otot › Virginia
Kajian klinikal Kanser Pundi Kencing Bukan Invasif Otot di Virginia
6 kajian untuk Kanser Pundi Kencing Bukan Invasif Otot sedang mencari peserta di lokasi di Virginia.
Teks kajian rasmi (Bahasa Inggeris)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- VCU Massey Comprehensive Cancer Center, Richmond
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Urology of Virginia ( Site 0125), Virginia Beach
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06833073Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Virginia Urology, Richmond
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05951179LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- University of Virginia Comprehensive Cancer Center, Charlottesville
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT04752722ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- Potamac Urology Center, Alexandria
Mengambil pesertaFasa 1/2
Umur 18 hingga 85 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06800963Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)
- University of Virginia, Charlottesville
Mengambil peserta
Umur 18 hingga 90 · Semua jantina · Dikemas kini 16 Dis 2024 · NCT05790850Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.